Remove tag therapeutic-development
article thumbnail

Frost & Sullivan's Top 10 predictions for healthcare in 2021

Healthcare IT News - Telehealth

More than 50% of the expected production capacity of the vaccine candidates, which are in Phase III and are getting emergency approval have been pre-booked by developed economies such as the US, EU, Japan, Canada, and the UK. Behavioral health will drive 3X increased growth in the digital therapeutics market from 2021 to 2023.

article thumbnail

Ambulatory surgery center's virtual care platform helps boost productivity and patient satisfaction

Healthcare IT News - Telehealth

To help meet this goal, the ambulatory surgery center contracted with health IT vendor Force Therapeutics, which offers a digital care management platform that leverages clinical data and custom protocols to educate patients and monitor their progress throughout an episode of care. To read the special report, click here. " RESULTS.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SQA News | Summer 2021

SQA

Attending from SQA were Gilberto Jimenez, Global Field Engineer Director and Brad Schultz , Executive VP of Business Development. Recently, our EVP of Business Development, Brad Schultz, found himself visiting SQA’s strategic partners at the Google Mountain View campus, riding the same bikes we saw in the movies. partnerships.

Nurses 88
article thumbnail

Potential of Implementing Polygenic Risk Scores in Healthcare Systems

HIT Consultant

The promise of personalized medicine is a world in which interventions, screening, and therapeutics are targeted to those most likely to get the disease. It is now possible to construct a polygenic risk score (PRS) to identify how genetic variation across the genome affects your chances of developing breast cancer. Ancestry Bias.

Doctors 52
article thumbnail

A guide to connected health device and remote patient monitoring vendors

Healthcare IT News - Telehealth

Biofourmis’ primary therapeutic focus areas include heart failure and other cardiometabolic disorders, pain, and oncology. Biofourmis’ digital therapeutics are used for RPM across three primary healthcare stakeholder groups: health systems, payers and pharmaceutical companies.

COVID-19 188
article thumbnail

Health Provider News

Hall Render

fraud scheme Nursing home must face vaccine-related wrongful firing claim, but not $2M retaliation accusations Transgender woman sues employer, Harvard Pilgrim for discrimination MICHIGAN 48-unit senior housing development could go up next to Vicksburg Halls in Marysville Can ads help a Michigan nursing home fix a staffing crisis?

article thumbnail

Health Provider News

Hall Render

to Develop Wearable Blood Loss Detector An Academic Lifeline for Rural Hospitals CHI St. in suit against Cleveland Clinic physician SPR Therapeutics leads local Q1 fundings as VC investors remain cautious Two Cincinnati businesswomen named to prestigious Inc. State roots raises $4 million N.C. Could it work in Lafayette?